Regarding γ′ fibrinogen levels as a biomarker of COVID-19 respiratory disease severity

被引：0
|
作者：
Kornblith, Lucy Z. [1 ]
Sadhanandhan, Bindhya [2 ]
Arun, Sreepriya [2 ]
Long, Rebecca [3 ,7 ]
Johnson, Alicia J. [4 ]
Noll, Jamie [5 ]
Ramchand, C. N. [6 ]
Olynyk, John K. [3 ,7 ]
Farrell, David H. [4 ,8 ]
机构：
[1] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA
[2] Theragen Biol Pvt Ltd, Chennai, India
[3] Fiona Stanley Fremantle Hosp Grp, Murdoch, WA, Australia
[4] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR USA
[5] Gamma Diagnost, Portland, OR USA
[6] MagGenome Pvt Ltd, Chennai, India
[7] Edith Cowan Univ, Joondalup, WA, Australia
[8] Oregon Hlth & Sci Univ, Donald D Trunkey Ctr Civilian & Combat Casualty Ca, Mail Stop L611,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA
来源：
BLOOD CELLS MOLECULES AND DISEASES | 2024年 / 105卷
关键词：
D O I：
10.1016/j.bcmd.2024.102825
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Regarding γ′ fibrinogen levels as a biomarker of COVID-19 respiratory disease severity
    Wang, Sangsang
    Yu, Diao
    Zhang, Junwu
    BLOOD CELLS MOLECULES AND DISEASES, 2024, 105
  • [2] ?' fibrinogen levels as a biomarker of COVID-19 respiratory disease severity
    Kornblith, Lucy Z.
    Sadhanandhan, Bindhya
    Arun, Sreepriya
    Long, Rebecca
    Johnson, Alicia J.
    Noll, Jamie
    Ramchand, C. N.
    Olynyk, John K.
    Farrell, David H.
    BLOOD CELLS MOLECULES AND DISEASES, 2023, 101
  • [3] Gamma' Fibrinogen Levels As a Biomarker of COVID-19 Severity
    Kornblith, Lucy Z.
    Sadhanandhan, Bindhya
    Arun, Sreepriya
    Long, Rebecca
    Johnson, Alicia J.
    Noll, Jamie
    Ramchand, Cn
    Olynyk, John K.
    Farrell, David H.
    BLOOD, 2022, 140 : 2749 - 2750
  • [4] Serum calprotectin as a novel biomarker for severity of COVID-19 disease
    Kaya, Tezcan
    Yaylaci, Selcuk
    Nalbant, Ahmet
    Yildirim, Ilhan
    Kocayigit, Havva
    Cokluk, Erdem
    Sekeroglu, Mehmet Ramazan
    Koroglu, Mehmet
    Guclu, Ertugrul
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (01) : 59 - 64
  • [5] Serum calprotectin as a novel biomarker for severity of COVID-19 disease
    Tezcan Kaya
    Selçuk Yaylacı
    Ahmet Nalbant
    İlhan Yıldırım
    Havva Kocayiğit
    Erdem Çokluk
    Mehmet Ramazan Şekeroğlu
    Mehmet Köroğlu
    Ertuğrul Güçlü
    Irish Journal of Medical Science (1971 -), 2022, 191 : 59 - 64
  • [6] Proteinuria as a Biomarker for COVID-19 Severity
    Ouahmi, Hajar
    Courjon, Johan
    Morand, Lucas
    Francois, Juliette
    Bruckert, Vincent
    Lombardi, Romain
    Esnault, Vincent
    Seitz-Polski, Barbara
    Demonchy, Elisa
    Dellamonica, Jean
    Boyer-Suavet, Sonia
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [7] Serum biomarker panel for disease severity and prognosis in patients with COVID-19
    Li, Jing
    Tang, Mingyang
    Liu, Didi
    Xie, Zongyu
    Wang, Fengchao
    Yang, Yanqing
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2023, 37 (02)
  • [8] Soluble Siglec-9 as a Biomarker for COVID-19 Disease Severity
    Fazal, Abid
    Shahul, Sajid
    Dreixler, John
    ANESTHESIA AND ANALGESIA, 2022, 134 : 287 - 288
  • [9] Immature platelets as a biomarker for disease severity and mortality in COVID-19 patients
    Welder, Daniel
    Jeon-Slaughter, Haekyung
    Ashraf, Bilal
    Choi, Sung-Hee
    Chen, Weina
    Ibrahim, Ibrahim
    Bat, Taha
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (03) : 530 - 536
  • [10] D-Dimer as a potential biomarker for disease severity in COVID-19
    Ozen, Mert
    Yilmaz, Atakan
    Cakmak, Vefa
    Beyoglu, Resad
    Oskay, Alten
    Seyit, Murat
    Senol, Hande
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2021, 40 : 55 - 59
12345